To explore the molecular mechanism by which UBE3A promotes tumor progression, we performed mass spectrometry to identify proteins that interacted with UBE3A, using PSDM11 as a positive control 19 (Figure 3A). The gene discussed is UBE3A; the disease is neoplasm.